about
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a ...
Read More
1.23
0.02
(1.65%)
134.2K
XNAS Volume
High vol. this week
XNAS 03 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..